杨长青,孙文嘉,夏东亚,朴虎日,郑艳,郭涛
YANG Chang-qing1,SUN Wen-jia2,XIA Dong-ya3,PIAO Hu-ri1,ZHENG Yan1,GUO Tao3 (1.College of Pharmacy

• 1:延边大学药学院
• 2:大连医科大学药学院
• 3:沈阳军区总医院药剂科
• 4:延边大学药学院

摘要(Abstract)：

目的研究汉族和朝鲜族健康志愿者单剂量口服氟康唑片的药物动力学。方法健康汉族和朝鲜族受试者各10名,男女各半,口服氟康唑片200 mg,定时采血,用RP-HPLC法测定血药质量浓度,用drug and statistics(DAS 2.0.1)软件程序进行数据处理,用SPSS软件程序进行统计分析。结果汉族和朝鲜族受试者主要药物动力学参数ρmax为(4.91±0.67)、(4.70±0.86)mg.L-1;tmax为(1.90±0.90)、(2.55±1.07)h;t1/2为(33.07±5.90)、(31.02±6.02)h;AUC(0-96)为(189.61±32.91)、(183.75±31.83)mg.h.L-1,AUC(0-∞)为(219.21±40.46)、(209.93±46.37)mg.h.L-1。统计结果显示两民族受试者主要药物动力学参数差异无统计学意义。结论汉族、朝鲜族两民族的种族差异对氟康唑片的药物动力学无影响。
Objective To investigate the pharmacokinetics of fluconazole tablets after oral administration in Chinese Han and Korean healthy volunteers.Methods Ten healthy volunteers of Chinese Han and Korean healthy volunteers(5 male and 5 female) were given 200 mg fluconazole tablets,and blood samples were taken at predetermined times.The concentrations of fluconazole in plasmas were determined by RP-HPLC method and the pharmacokinetic parameters were calculated by drug and statistics software(DAS ver 2.0.1).Results The pharmacokinetic parameters of 2 nations were as follows:ρmax were(4.91±0.67),(4.70±0.86)mg·L-1,tmax were(1.90±0.90),(2.55±1.07) h,t1/2 were(33.07±5.90),(31.02±6.02)h,AUC(0-96) were(189.61±32.91),(183.75±31.83)mg·h·L-1,AUC(0-∞) were(219.21±40.46),(209.93±46.37)mg·h·L-1,respectively.The results of statistical analysis showed no significant difference in the main pharmacokinetics of fluconazole tablets between two races.Conclusions The ethnic difference between Chinese Han and Korean has no influence on the pharmacokinetics of fluconazole tablets.

关键词(KeyWords)： 氟康唑片;药物动力学;反相高效液相色谱法;汉族人;朝鲜族人
fluconazole tablet;pharmacokinetics;RP-HPLC;Chinese Han;Chinese Korean

Abstract:

Keywords:

基金项目(Foundation): 全军医学科学技术研究“十一五”计划科技攻关课题基金资助项目(06G023)

作者(Author): 杨长青,孙文嘉,夏东亚,朴虎日,郑艳,郭涛
YANG Chang-qing1,SUN Wen-jia2,XIA Dong-ya3,PIAO Hu-ri1,ZHENG Yan1,GUO Tao3 (1.College of Pharmacy

参考文献(References)：

• [1]陈新谦,金有豫,汤光,等.新编药物学[M].北京:人民卫生出版社,2003:125-126.
• [2]杜智敏,孙考祥,张波.氟康唑胶囊人体生物利用度及药动学研究[J].中国药学杂志,2006,41(6):451-453.
• [3]DUSAN J,VESNA K,BILJANA C A.Randomized,open-label pharmacokinetic comparison of two oral for-mulations of fluconazole 150 mg in healthy adult volun-teers[J].Clinical Therapeutics,2005,27(10):1588-1593.
• [4]KARTHIK V,LISA L,DAVID J.Effects of the anti-fungal agents on oxidative drug metabolism[J].ClinPharmacokinet,2000,38(2):111-180.
• [5]王雪丁,黄丽慧,曾桂雄,等.氟康唑胶囊的人体药物动力学及其生物利用度[J].中国临床药理学杂志,2002,18(3):207-210.
• [6]邓鸣,刘会臣.性别对药物动力学的影响[J].中国临床药理学杂志,2004,20(1):68-70.